1. Home
  2. ONON vs NTRA Comparison

ONON vs NTRA Comparison

Compare ONON & NTRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ONON
  • NTRA
  • Stock Information
  • Founded
  • ONON 2010
  • NTRA 2003
  • Country
  • ONON Switzerland
  • NTRA United States
  • Employees
  • ONON N/A
  • NTRA N/A
  • Industry
  • ONON Shoe Manufacturing
  • NTRA Medical Specialities
  • Sector
  • ONON Consumer Discretionary
  • NTRA Health Care
  • Exchange
  • ONON Nasdaq
  • NTRA Nasdaq
  • Market Cap
  • ONON 19.4B
  • NTRA 21.5B
  • IPO Year
  • ONON 2021
  • NTRA 2015
  • Fundamental
  • Price
  • ONON $54.34
  • NTRA $162.56
  • Analyst Decision
  • ONON Strong Buy
  • NTRA Strong Buy
  • Analyst Count
  • ONON 20
  • NTRA 16
  • Target Price
  • ONON $61.90
  • NTRA $185.56
  • AVG Volume (30 Days)
  • ONON 5.7M
  • NTRA 1.3M
  • Earning Date
  • ONON 08-12-2025
  • NTRA 08-07-2025
  • Dividend Yield
  • ONON N/A
  • NTRA N/A
  • EPS Growth
  • ONON 61.26
  • NTRA N/A
  • EPS
  • ONON 0.71
  • NTRA N/A
  • Revenue
  • ONON $2,869,732,450.00
  • NTRA $1,831,000,000.00
  • Revenue This Year
  • ONON $29.06
  • NTRA $19.92
  • Revenue Next Year
  • ONON $24.47
  • NTRA $16.02
  • P/E Ratio
  • ONON $75.43
  • NTRA N/A
  • Revenue Growth
  • ONON 34.92
  • NTRA 51.50
  • 52 Week Low
  • ONON $34.59
  • NTRA $92.14
  • 52 Week High
  • ONON $64.05
  • NTRA $183.00
  • Technical
  • Relative Strength Index (RSI)
  • ONON 52.96
  • NTRA 48.01
  • Support Level
  • ONON $51.19
  • NTRA $158.00
  • Resistance Level
  • ONON $55.95
  • NTRA $170.48
  • Average True Range (ATR)
  • ONON 1.76
  • NTRA 5.35
  • MACD
  • ONON -0.04
  • NTRA -1.27
  • Stochastic Oscillator
  • ONON 68.94
  • NTRA 29.39

About ONON On Holding AG

On Holding AG is a premium performance sports brand rooted in technology, design, and impact. Its shoes, apparel, and accessories products are designed predominantly for athletic use, casual, or leisure purposes. It does not manufacture the products or the raw materials and relies instead on third-party suppliers and contract manufacturers. Geographically, it derives a majority of its revenue from the Americas and rest from Europe, Middle East and Africa and Asia-Pacific region.

About NTRA Natera Inc.

Natera Inc is a diagnostic and research company with proprietary molecular and bioinformatics technology. The company's key product offerings include its Panorama Non-Invasive Prenatal Test (NIPT) which screens for chromosomal abnormalities of a fetus as well as in twin pregnancies, typically with a blood draw from the mother, Horizon Carrier Screening (HCS) to determine carrier status for a large number of severe genetic diseases that could be passed on to the carrier's children, Signatera molecular residual disease (MRD) test, which detects circulating tumor DNA in patients previously diagnosed with cancer to assess molecular residual disease and monitor for recurrence; and Prospera, to assess organ transplant rejection.

Share on Social Networks: